Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS.

J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8.

PMID:
10491430
2.

Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

Vogel VG.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4413s-4418s; discussion 4411s-4412s. Review.

PMID:
11916233
3.

Mammographic screening in older women. Is it worthwhile?

van Dijck JA, Broeders MJ, Verbeek AL.

Drugs Aging. 1997 Feb;10(2):69-79. Review.

PMID:
9061265
4.

[Natural history of minimal and occult breast cancers. Long term survival and mass screening].

Couray J.

Rev Fr Gynecol Obstet. 1992 Nov;87(11):548-60. Review. French.

PMID:
1480925
5.

The relationship between age and incidence of breast cancer. Population and screening program data.

Kessler LG.

Cancer. 1992 Apr 1;69(7 Suppl):1896-903. Review.

PMID:
1544088
6.

[Breast cancer screening between forty and fifty years old].

Raulic P, Favre C.

Contracept Fertil Sex. 1997 Jan;25(1):XI-XVII. Review. French. No abstract available.

PMID:
9064046
7.

Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review.

Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L.

Lancet Oncol. 2007 Dec;8(12):1129-38. Review.

PMID:
18054882
8.

Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years.

Feig SA.

Cancer. 1995 May 15;75(10):2412-9. Review. No abstract available.

PMID:
7736383
9.

Understanding breast cancer risk.

Anderson RL.

Radiol Technol. 2010 May-Jun;81(5):457M-476M. Review.

PMID:
20445140
10.

Interpreting overdiagnosis estimates in population-based mammography screening.

de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ.

Epidemiol Rev. 2011;33:111-21. doi: 10.1093/epirev/mxr009. Review.

PMID:
21709144
11.

Breast cancer in elderly women.

Rahman F.

Tex Med. 1992 May;88(5):71-2. Review. No abstract available.

PMID:
1609370
12.

[Breast cancer. A historical account, present and future].

Lazcano-Ponce EC, Tovar-Guzmán V, Alonso-de Ruiz P, Romieu I, López-Carrillo L.

Salud Publica Mex. 1996 Mar-Apr;38(2):139-52. Review. Spanish.

PMID:
8693352
13.

A review of the technical features of breast cancer screening illustrated by a specific model using South Australian cancer registry data.

O'Neill TJ, Tallis GM, Leppard P.

Stat Methods Med Res. 1995 Mar;4(1):55-72. Review.

PMID:
7613638
14.

The significance of the rising incidence of breast cancer in the United States.

Miller BA, Feuer EJ, Hankey BF.

Important Adv Oncol. 1994:193-207. Review. No abstract available.

PMID:
8206490
15.

One in nine: risks and prevention strategies for breast cancer.

Appling SE.

Medsurg Nurs. 1996 Feb;5(1):62-4. Review. No abstract available.

PMID:
8696413
16.

Strengths and limitations of breast cancer risk assessment.

Baltzell K, Wrensch MR.

Oncol Nurs Forum. 2005 May 10;32(3):605-16. Review.

PMID:
15897935
17.

Statistical models for cancer screening.

Stevenson CE.

Stat Methods Med Res. 1995 Mar;4(1):18-32. Review.

PMID:
7613635
18.

A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.

Meads C, Ahmed I, Riley RD.

Breast Cancer Res Treat. 2012 Apr;132(2):365-77. doi: 10.1007/s10549-011-1818-2. Review.

PMID:
22037780
19.

Risk prediction models of breast cancer: a systematic review of model performances.

Anothaisintawee T, Teerawattananon Y, Wiratkapun C, Kasamesup V, Thakkinstian A.

Breast Cancer Res Treat. 2012 May;133(1):1-10. doi: 10.1007/s10549-011-1853-z. Review.

PMID:
22076477
20.

Retrospective reviews of breast cancer screening: what do we really learn from them?

Moskowitz M.

Radiology. 1996 Jun;199(3):615-20. Review. No abstract available.

PMID:
8637974
Items per page

Supplemental Content

Support Center